SEC Tracker
Get the app

Cellectis CLLS

Cellectis to report Q3 2026 results on Nov 12

Cellectis (CLLS) filed a 6-K with the SEC on Nov 9, 2026, 4:35 pm ET. Source: the filing on SEC EDGAR.

Foreign issuer report

Form
6-K
Filed
Importance
Notable
  1. Q3 2026 financial results to be reported on Nov 12, 2026
  2. Investor conference call scheduled for Nov 13, 2026 at 8:00 a.m. ET
  3. Company focuses on genetic medicines for lifelong treatment diseases

Written from the 6-K on EDGAR. AI can make mistakes. Check the filing.

Get the appView on EDGAR

Get an email when Cellectis files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Data on this page was fetched . The filing on SEC.gov is the record.